GTS5:Table of Contents: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 92: | Line 92: | ||
'''Homologous recombination''' | '''Homologous recombination''' | ||
- [[GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] | - [[GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] | ||
- [[GTS5:PALB2-related cancer predisposition syndrome (PALB2)]] | - [[GTS5:PALB2-related cancer predisposition syndrome (PALB2)]] | ||
| Line 127: | Line 126: | ||
==Telomere maintenance ([[GTS5:Telomere maintenance|Overview Page Link]])== | ==Telomere maintenance ([[GTS5:Telomere maintenance|Overview Page Link]])== | ||
'''Telomere biology disorders''' | '''Telomere biology disorders''' | ||
- [[GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]] | - [[GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]] | ||